Resonant Capital Advisors, LLC Intellia Therapeutics, Inc. Transaction History

Resonant Capital Advisors, LLC

  • $1.34 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024
SELL
$20.02 - $27.22 $5,105 - $6,941
-255 Reduced 0.62%
41,199 $922,000
Q1 2024

May 01, 2024
BUY
$23.82 - $32.8 $2,524 - $3,476
106 Added 0.26%
41,454 $1.14 Million
Q4 2023

Jan 31, 2024
BUY
$23.16 - $32.34 $233,499 - $326,051
10,082 Added 32.25%
41,348 $1.26 Million
Q3 2023

Oct 31, 2023
BUY
$31.62 - $45.78 $988,630 - $1.43 Million
31,266 New
31,266 $988,000

Others Institutions Holding NTLA

# of Institutions
314
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $867M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Resonant Capital Advisors, LLC Portfolio

Follow Resonant Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resonant Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resonant Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email